India-based pharmaceutical company, Dr Reddy’s Laboratories, has announced an intended public offer to acquire the issued and outstanding shares of OctoPlus NV for an offer price of EU €27.39 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback